American Shared Hospital Services (AMS) reported a fourth‑quarter 2025 revenue of $7.7 million, a net loss of $631,000, and earnings per share of –$0.09, falling short of the consensus estimate of $0.02 per share. The quarter’s loss narrowed from the $1.3 million loss recorded in Q4 2024, but the company still missed analysts’ expectations for earnings.
For the full year, AMS generated $28.1 million in revenue, a slight decline from $28.3 million in 2024, and posted a net loss of $1.6 million, a reversal from the $2.2 million net income reported in 2024. Earnings per share for the year were –$0.23 versus $0.33 in 2024. Gross margin contracted to 12% in Q4 2025 from 35% in Q4 2024, reflecting the impact of a lower‑margin direct‑services mix and the capital‑intensive expansion of treatment centers.
The company’s direct‑services segment grew 23.7% year‑over‑year to $15.5 million, while the leasing segment declined as several long‑term contracts expired. LINAC revenue also rose 35.4% year‑over‑year, underscoring the strength of the company’s high‑margin equipment sales. The mix shift toward direct patient care, which carries lower margins, and the increased operating costs associated with building new centers are the primary drivers of the margin compression seen this year.
On April 6 2026, AMS secured a seven‑year lease extension with Orlando Health for its proton therapy system, extending the agreement through April 5 2033. The extension provides a stable, long‑term revenue stream and reinforces a key partnership that has been central to AMS’s strategy of expanding its direct‑services footprint.
The results illustrate the company’s ongoing transition from a leasing‑focused model to a direct‑patient‑services platform. While the shift has generated strong growth in the direct‑services segment, the associated capital expenditures and the loss of high‑margin leasing revenue have pressured profitability. Headwinds include contract expirations, lower PBRT volumes, and higher operating costs, whereas tailwinds are the growth of direct services, robust LINAC revenue, and the secured Orlando Health lease. The company’s financial outlook remains focused on scaling its direct‑services operations while managing the short‑term impact of the transition on margins.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.